{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T20:41:26Z","timestamp":1792960886156,"version":"4.5.0"},"reference-count":26,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Technology &amp; Therapeutics"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>We evaluated accuracy and safety of a seventh-generation real-time continuous glucose monitoring (CGM) system during pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      Evaluable data for accuracy analysis were obtained from 96 G7 sensors (Dexcom, Inc.) worn by 96 of 105 enrolled pregnant women with type 1 (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u200959), type 2 (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u200921), or gestational diabetes (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u200925). CGM values were compared with arterialized venous glucose values from the YSI comparator instrument during 6-h clinic sessions at different time points throughout the sensors' 10-day wear period. The primary endpoint was the proportion of CGM values in the 70\u2013180 mg\/dL range within 15% of comparator glucose values. Secondary endpoints included the proportion of CGM values within 20% or 20 mg\/dL of comparator values \u2265 or &lt;100 mg\/dL, respectively (the %20\/20 agreement rate).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of the 1739 pairs with CGM in the 70\u2013180 mg\/dL range, 83.2% were within 15% of comparator values. The lower bound of the 95% confidence interval was 79.8%. Of the 2102 pairs with CGM values in the 40\u2013400 mg\/dL range, the %20\/20 agreement rate was 92.5%. Of the 1659 pairs with comparator values in the 63\u2013140 mg\/dL range, the %20\/20 agreement rate was 92.3%. The %20\/20 agreement rates on days 1, 4 and 7, and 10 were 78.6%, 96.3%, and 97.3%, respectively. Consensus error grid analysis showed 99.8% of pairs in the clinically acceptable A and B zones. There were no serious adverse events. The sensors' 10-day survival rate was 90.3%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The G7 system is accurate and safe during pregnancies complicated by diabetes and does not require confirmatory fingerstick testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trial Registration:<\/jats:title>\n                    <jats:p>\n                      <jats:uri xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/clinicaltrials.gov\">clinicaltrials.gov<\/jats:uri>\n                      NCT04905628\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/dia.2023.0516","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T11:38:36Z","timestamp":1707133116000},"page":"307-312","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":18,"title":["Performance of the Dexcom G7 Continuous Glucose Monitoring System in Pregnant Women with Diabetes"],"prefix":"10.1177","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7602-0396","authenticated-orcid":false,"given":"Sarit","family":"Polsky","sequence":"first","affiliation":[{"name":"Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3832-2024","authenticated-orcid":false,"given":"Amy M.","family":"Valent","sequence":"additional","affiliation":[{"name":"Oregon Health and Science University, Portland, Oregon, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3477-0305","authenticated-orcid":false,"given":"Elvira","family":"Isganaitis","sequence":"additional","affiliation":[{"name":"Joslin Diabetes Center and Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6386-9203","authenticated-orcid":false,"given":"Kristin","family":"Castorino","sequence":"additional","affiliation":[{"name":"Sansum Diabetes Research Institute, Santa Barbara, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grenye","family":"O'Malley","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, New York, New York, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stayce E.","family":"Beck","sequence":"additional","affiliation":[{"name":"Department of Clinical Affairs, Dexcom, Inc., San Diego, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Clinical Affairs, Dexcom, Inc., San Diego, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9675-3001","authenticated-orcid":false,"given":"Lori M.","family":"Laffel","sequence":"additional","affiliation":[{"name":"Joslin Diabetes Center and Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9589-4996","authenticated-orcid":false,"given":"Florence M.","family":"Brown","sequence":"additional","affiliation":[{"name":"Joslin Diabetes Center and Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3492-2578","authenticated-orcid":false,"given":"Carol J.","family":"Levy","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, New York, New York, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"key":"e_1_3_4_2_2","first-page":"72","article-title":"QuickStats: Percentage of mothers with gestational diabetes, by maternal age\u2014National vital statistics system, United States, 2016 and 2021","author":"Centers for Disease Control and Prevention","year":"2023","unstructured":"Centers for Disease Control and Prevention. QuickStats: Percentage of mothers with gestational diabetes, by maternal age\u2014National vital statistics system, United States, 2016 and 2021. MMWR Morb Mortal Wkly Rep, 2023; 72.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2022.12.006"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002501"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002961"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707943"},{"key":"e_1_3_4_7_2","first-page":"515","article-title":"Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus","volume":"84","author":"Rosenn B","year":"1994","unstructured":"Rosenn B, , Miodovnik M, , Combs CA, et al. Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet Gynecol, 1994; 84:515\u2013520.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2017.1402880"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1790"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-9020"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-015-0579-4"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4332"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32400-5"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13988"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.2337\/db19-351-OR"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1218602"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0143"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0150"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2020.0085"},{"key":"e_1_3_4_20_2","unstructured":"Dexcom I. G6 user guide rev 13 LBL014003 Rev 013 MT23976. 2022."},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2022.0011"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.2196\/42057"},{"key":"e_1_3_4_23_2","article-title":"Comparisons of fifth-, sixth-, and seventh-generation continuous glucose monitoring systems","author":"Welsh JB","year":"2022","unstructured":"Welsh JB, , Psavko S, , Zhang X, et al. Comparisons of fifth-, sixth-, and seventh-generation continuous glucose monitoring systems. J Diabetes Sci Technol, 2022:19322968221099879.","journal-title":"J Diabetes Sci Technol"},{"key":"e_1_3_4_24_2","unstructured":"Dexcom. Can Dexcom G7 be worn during pregnancy? LBL-1002962 Rev001 2023. Available from: https:\/\/www.dexcom.com\/en-us\/faqs\/can-dexcom-be-worn-during-pregnancy [Last accessed: August11 2023]."},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.8.1143"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1177\/19322968221091816"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-S015"}],"container-title":["Diabetes Technology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/dia.2023.0516","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/dia.2023.0516","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/dia.2023.0516","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:14:35Z","timestamp":1777400075000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/dia.2023.0516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1089\/dia.2023.0516"],"URL":"https:\/\/doi.org\/10.1089\/dia.2023.0516","relation":{},"ISSN":["1520-9156","1557-8593"],"issn-type":[{"value":"1520-9156","type":"print"},{"value":"1557-8593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,30]]}}}